Reduction of Infectivity of SARS-CoV-2 by Zinc Oxide Coatings
Source abstract
Abstract
We developed antimicrobial coatings from ZnO particles that reduce the infectivity of SARS-CoV-2 suspensions by >99.9% in 1 h. The advantage of a coating is that it can be applied to a variety of objects, e.g., hand rails and door knobs, to hinder the spread of disease. Two porous coatings were prepared: one from submicrometer zinc oxide particles bound with silica menisci and the other from zinc oxide tetrapods bound with polyurethane. Experiments on glass coatings show that infectivity depends on porosity for hydrophilic materials, wherein aqueous droplets are imbibed into the pores.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Infection Control and Ventilation · SARS-CoV-2 detection and testing · Dental Research and COVID-19
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical Engineering and Center for Soft Matter and Biological Physics, Virginia Tech, Blacksburg, Virginia 24061, United States
School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China
Centre for Immunity and Infection, Hong Kong Science Park, Hong Kong, China
HKU-Pasteur Research Pole, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China
Funding
Health and Medical Research Fund · National Institute of Allergy and Infectious Diseases · Division of Chemical, Bioengineering, Environmental, and Transport Systems · National Science Foundation
References (44)
Show source-provided references
1. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Johns Hopkins University.https://coronavirus.jhu.edu/map.html (accessed 2021-04-25).
2. 10.1126/science.abc619710.1126/science.abc6197 ↗
3. 10.1017/S002217240001928810.1017/S0022172400019288 ↗
4. 10.1038/s41586-020-2342-510.1038/s41586-020-2342-5 ↗
5. 10.1101/2021.04.24.2125604410.1101/2021.04.24.21256044 ↗
6. 10.1056/NEJMc200497310.1056/NEJMc2004973 ↗
7. 10.1016/S2666-5247(20)30003-310.1016/S2666-5247(20)30003-3 ↗
8. 10.1017/S095026882000256310.1017/S0950268820002563 ↗
9. Clinical Questions about COVID-19: Questions and Answers. Centers for Disease Control and Prevention (CDC). https://www.cdc.gov/coronavirus/2019-ncov/hcp/faq.html (accessed 2020-05-26).
10. 10.1016/j.cocis.2021.10148110.1016/j.cocis.2021.101481 ↗
11. 10.1086/50236910.1086/502369 ↗
12. 10.1021/acsami.0c1142510.1021/acsami.0c11425 ↗
13. 10.1021/acsami.0c1946510.1021/acsami.0c19465 ↗
14. 10.1016/j.mfglet.2020.08.00710.1016/j.mfglet.2020.08.007 ↗
15. 10.1016/j.envres.2021.11094710.1016/j.envres.2021.110947 ↗
16. 10.1021/acsbiomaterials.0c0109110.1021/acsbiomaterials.0c01091 ↗
17. 10.12688/wellcomeopenres.16577.110.12688/wellcomeopenres.16577.1 ↗
18. 10.3390/coatings1104038810.3390/coatings11040388 ↗
19. 10.1021/acsami.1c0441210.1021/acsami.1c04412 ↗
20. 10.1002/jbm.b.3162010.1002/jbm.b.31620 ↗
21. 10.1088/0957-4484/23/49/49510110.1088/0957-4484/23/49/495101 ↗
22. 10.4049/jimmunol.150237310.4049/jimmunol.1502373 ↗
23. 10.1186/s12929-019-0563-410.1186/s12929-019-0563-4 ↗
24. 10.1016/j.apsusc.2009.04.19810.1016/j.apsusc.2009.04.198 ↗
25. 10.3390/nano1105131210.3390/nano11051312 ↗
26. 10.1016/j.colsurfb.2018.04.05810.1016/j.colsurfb.2018.04.058 ↗
27. 10.3390/polym1207153510.3390/polym12071535 ↗
28. 10.1002/adfm.20110298010.1002/adfm.201102980 ↗
29. 10.1016/j.jcis.2020.10.01410.1016/j.jcis.2020.10.014 ↗
30. 10.1016/0021-9797(68)90272-510.1016/0021-9797(68)90272-5 ↗
31. 10.1002/adma.20120049110.1002/adma.201200491 ↗
32. 10.1063/5.003792410.1063/5.0037924 ↗
33. FDA Code of Federal Regulations Title 21. U.S. Food & Drug Administrationhttps://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=582&showFR=1.
34. 10.1016/j.cbi.2018.03.00810.1016/j.cbi.2018.03.008 ↗
35. 10.1128/AEM.02149-1010.1128/AEM.02149-10 ↗
36. 10.1021/la104825u10.1021/la104825u ↗
37. 10.1007/s40820-015-0040-x10.1007/s40820-015-0040-x ↗
38. 10.3389/fmicb.2017.0016710.3389/fmicb.2017.00167 ↗
39. 10.1021/la991013x10.1021/la991013x ↗
40. 10.3390/nano1102026310.3390/nano11020263 ↗
41. 10.1111/ijac.1314410.1111/ijac.13144 ↗
42. 10.3390/ma310484210.3390/ma3104842 ↗
43. 10.1186/s12985-020-01418-710.1186/s12985-020-01418-7 ↗
44. 10.1021/acs.est.9b0495910.1021/acs.est.9b04959 ↗